Dr Helen Pearson
Position:
- Postdoctoral, Research (Cell Cycle and Cancer Genetics), Peter MacCallum Cancer Institute
Biography:
Throughout her degree in Biochemistry Dr Pearson developed an interest in cell signalling and the molecular genetics of cancer biology. To this end, she undertook a summer studentship assisting a breast cancer clinical trial which attracted me further towards the field of cancer research. Subsequently, she secured a PhD position at Cardiff University with Prof Alan Clarke where she developed and characterised novel models of prostate cancer. During this research Dr Pearson became fascinated with the molecular mechanisms that predispose prostate cancer, which led her to undertake a postdoctoral position with Dr Patrick Humbert investigating the role of the polarity regulators and prostate cancer.
Current areas of collaboration:
Ras signalling, Scribble, cancer initiation, cancer progression, cell polarity, chemoprevention, endogenous factors, exogenous factors, genes/genetic polymorphisms, marker discovery, metastases, oncogenes and tumour suppressor genes, prostate cancer transgenic models, scientific model systems, technology development.
